Grow your business safely with PHARMACIE CENTRALE

All the information you need about PHARMACIE CENTRALE to develop and secure your business in France

P HOME > CORPORATES > PHARMACIE CENTRALE > BALANCE SHEET ( 2017-03-07)

THE LIST OF BALANCE SHEET : PHARMACIE CENTRALE

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-12-20 Public 2021-10-31 Complete
2021-10-04 Public 2020-10-31 Complete
2020-09-25 Public 2019-10-31 Complete
2019-02-06 Public 2017-10-31 Complete
2017-11-16 Partially confidential 2017-06-30 Complete
2017-03-07 Partially confidential 2016-06-30 Complete
NamePHARMACIE CENTRALE
Siren441706561
Closing2016-06-30
Registry code 5752
Registration number 716
Management number2002D00090
Activity code 4773Z
Closing date n-12015-06-30
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2017-03-07
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPartially confidential
Address57350 Stiring-Wendel
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AF Concessions, Patents and Similar Rights 2 443.00 611.00 1 832.00 2 443.00
AH Goodwill 2 340 000.00 2 340 000.00 2 340 000.00
AR Technical installations, industrial equipment and tools 239 494.00 222 230.00 17 264.00 239 494.00
AT Other tangible assets 703 565.00 525 679.00 177 886.00 703 565.00
AX Advances and down payments 4 935.00 4 935.00 4 935.00
BJ TOTAL (I) 3 298 417.00 754 754.00 2 543 664.00 3 298 417.00
BT Goods 516 690.00 516 690.00 516 690.00
BX Customers and related accounts 88 832.00 88 832.00 88 832.00
BZ Other receivables 119 099.00 119 099.00 119 099.00
CD Marketable securities 61 180.00 61 180.00 61 180.00
CF Cash and cash equivalents 222 181.00 222 181.00 222 181.00
CH Prepaid expenses 8 062.00 8 062.00 8 062.00
CJ TOTAL (II) 1 016 044.00 1 016 044.00 1 016 044.00
CO Grand total (0 to V) 4 314 461.00 754 754.00 3 559 707.00 4 314 461.00
CU Other investments 1 746.00 1 746.00 1 746.00
CX Development or Research and Development Expenses 6 234.00 6 234.00 6 234.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 109 600.00 109 600.00 109 600.00
DB Share, merger, contribution premiums, etc. 31 600.00 31 600.00 31 600.00
DD Legal reserve (1) 10 960.00 8 960.00 10 960.00
DH Retained earnings 1 937 511.00 1 728 171.00 1 937 511.00
DI RESULTS FOR THE YEAR (Profit or Loss) 128 284.00 211 340.00 128 284.00
DL TOTAL (I) 2 217 954.00 2 089 671.00 2 217 954.00
DU Loans and Debts from Credit Institutions (3) 990 517.00 1 189 687.00 990 517.00
DV Miscellaneous Loans and Financial Debts (4) 1 711.00 27 649.00 1 711.00
DX Trade payables and related accounts 208 231.00 265 708.00 208 231.00
DY Tax and social security liabilities 141 293.00 116 257.00 141 293.00
EA Other liabilities 13 176.00
EC TOTAL (IV) 1 341 753.00 1 612 477.00 1 341 753.00
EE Grand total (I to V) 3 559 707.00 3 702 147.00 3 559 707.00
EG Accrued income and payables due within one year 555 124.00 621 960.00 555 124.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 3 272 127.00 40 130.00 3 272 127.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 6 234.00 6 234.00
I3 DECREASES Total Financial Fixed Assets 1 746.00
I4 DECREASES Grand Total 13 840.00 3 298 417.00
IN DECREASES Start-up, development, or research expenses 6 234.00
IO DECREASES Total including other intangible assets 2 342 443.00
IY DECREASES Total Tangible Fixed Assets 13 840.00 947 994.00
KD ACQUISITIONS Total including other intangible assets 2 340 000.00 2 443.00 2 340 000.00
LN ACQUISITIONS Total Tangible Fixed Assets 924 963.00 36 872.00 924 963.00
LQ ACQUISITIONS Total Financial Fixed Assets 931.00 815.00 931.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 630 055.00 137 660.00 12 961.00 630 055.00
CY DEPRECIATION Start-up, development, or research expenses 6 234.00 6 234.00
PE DEPRECIATION Total including other intangible assets 611.00
QU DEPRECIATION Total Tangible Fixed Assets 623 821.00 137 049.00 12 961.00 623 821.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8A Miscellaneous Loans and Financial Debts 328.00 328.00 328.00
8B Suppliers and Related Accounts 208 231.00 208 231.00 208 231.00
8C Staff and Related Accounts 41 245.00 41 245.00 41 245.00
8D Social Security and Other Social Organizations 47 777.00 47 777.00 47 777.00
UX Other trade receivables 88 832.00 88 832.00
VB VAT 3 810.00 3 810.00
VH Loans with a maturity of more than one year at origin 990 517.00 203 888.00 786 629.00 990 517.00
VI Group and Associates 1 383.00 1 383.00 1 383.00
VK Loans repaid during the year 199 170.00 199 170.00
VM Income taxes 67 148.00 67 148.00
VQ Other Taxes, Duties, and Similar Debts 39 042.00 39 042.00 39 042.00
VR Miscellaneous debtors (including receivables related to repo transactions) 36 111.00 36 111.00
VS Prepaid expenses 8 062.00 8 062.00
VT TOTAL – STATEMENT OF RECEIVABLES 215 993.00 215 993.00 215 993.00
VW VAT 13 230.00 13 230.00 13 230.00
VY TOTAL – STATEMENT OF LIABILITIES 1 341 753.00 555 124.00 786 629.00 1 341 753.00

all companies in France

Complete and comprehensive database.